Paysign Completes Transition of 123 Plasma Centers Ahead of Schedule, Boosting Growth Momentum
PAYSJune 11, 2025
Read more →Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
PAYSHENDERSON, Nev.--(BUSINESS WIRE)--Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
June 11, 2025Expansion
Read more →Paysign Awarded 132 Plasma Centers, Boosting U.S. Market Share And Driving Immediate Revenue Growth
PAYSJune 5, 2025
Read more →Forecasting The Future: 6 Analyst Projections For PaySign
PAYSMay 14, 2025
Read more →DA Davidson Maintains Buy on PaySign, Raises Price Target to $6
PAYSMay 14, 2025
Read more →PaySign Analysts Increase Their Forecasts After Better-Than-Expected Earnings
PAYSMay 9, 2025
Read more →Ladenburg Thalmann Maintains Buy on PaySign, Raises Price Target to $8.25
PAYSMay 9, 2025
Read more →Lake Street Maintains Buy on PaySign, Raises Price Target to $7
PAYSMay 9, 2025
Read more →PaySign Raises FY2025 Sales Guidance from $68.50M-$70.00M to $72.00M-$74.00M vs $69.40M Est
PAYSMay 8, 2025
Read more →PaySign Sees Q2 Sales $18.500M-$19.000M vs $17.63M Est
PAYSMay 8, 2025
Read more →PaySign Q1 EPS $0.05 Beats $0.02 Estimate, Sales $18.60M Beat $17.49M Estimate
PAYSMay 8, 2025
Read more →Barrington Research Maintains Outperform on PaySign, Lowers Price Target to $5
PAYSMarch 27, 2025
Read more →DA Davidson Maintains Buy on PaySign, Maintains $6 Price Target
PAYSMarch 26, 2025
Read more →Barrington Research Maintains Outperform on PaySign, Maintains $7 Price Target
PAYSMarch 26, 2025
Read more →Paysign Sees 2025 Revenue $68.5M-$70M vs $65.841M Est.; Sees Q1 Revenue $17.5M-$18M vs $15.242M Est.
PAYSMarch 25, 2025
Read more →PaySign Q4 2024 GAAP EPS $0.02, Inline, Sales $15.610M Beat $15.414M Estimate
PAYSMarch 25, 2025
Read more →Paysign Acquires Assets Of Gamma Innovation, Terms Not Disclosed
PAYSMarch 25, 2025
Read more →Lake Street Initiates Coverage On PaySign with Buy Rating, Announces Price Target of $6
PAYSDecember 20, 2024
Read more →Barrington Research Maintains Outperform on PaySign, Maintains $7 Price Target
PAYSNovember 6, 2024
Read more →PaySign Affirms FY2024 Sales Guidance to $56.50M-58.50M VS Est. 57.503M ; Adj. EBITDA: $9M-$10M.
PAYSNovember 5, 2024
Read more →PaySign Q3 2024 GAAP EPS $0.03 Beats $0.01 Estimate, Sales $15.256M Beat $14.822M Estimate
PAYSNovember 5, 2024
Read more →Barrington Research Maintains Outperform on PaySign, Maintains $7 Price Target
PAYSNovember 4, 2024
Read more →